Xinyu He - Search Results

Year	Number of Results
1995	1
2009	1
2010	1
2011	3
2012	1
2013	4
2014	5
2015	6
2016	5
2017	5
2018	10
2019	11
2020	10
2021	9
2022	25
2023	5

1

A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling.

Li RH, Tian T, Ge QW, He XY, Shi CY, Li JH, Zhang Z, Liu FZ, Sang LJ, Yang ZZ, Liu YZ, Xiong Y, Yan Q, Li X, Ju HQ, Liu J, Wang LJ, Shao JZ, Wang W, Zhou T, Lin A. Li RH, et al. Cell Res. 2021 Oct;31(10):1088-1105. doi: 10.1038/s41422-021-00530-9. Epub 2021 Jul 15. Cell Res. 2021. PMID: 34267352 Free PMC article.

2

Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer.

Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, Li Y. Cao H, et al. Among authors: he x. ACS Nano. 2016 Aug 23;10(8):7738-48. doi: 10.1021/acsnano.6b03148. Epub 2016 Jul 27. ACS Nano. 2016. PMID: 27454827

3

Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.

Shi C, Wang Y, Wu M, Chen Y, Liu F, Shen Z, Wang Y, Xie S, Shen Y, Sang L, Zhang Z, Gao Z, Yang L, Qu L, Yang Z, He X, Guo Y, Pan C, Che J, Ju H, Liu J, Cai Z, Yan Q, Yu L, Wang L, Dong X, Xu P, Shao J, Liu Y, Li X, Wang W, Zhou R, Zhou T, Lin A. Shi C, et al. Among authors: he x. Nat Commun. 2022 Nov 14;13(1):6951. doi: 10.1038/s41467-022-34346-x. Nat Commun. 2022. PMID: 36376293 Free PMC article.

4

Complement C1q (C1qA, C1qB, and C1qC) May Be a Potential Prognostic Factor and an Index of Tumor Microenvironment Remodeling in Osteosarcoma.

Chen LH, Liu JF, Lu Y, He XY, Zhang C, Zhou HH. Chen LH, et al. Front Oncol. 2021 May 17;11:642144. doi: 10.3389/fonc.2021.642144. eCollection 2021. Front Oncol. 2021. PMID: 34079754 Free PMC article.

5

Bacterial bioluminescence assay for bioanalysis and bioimaging.

Li Y, He X, Zhu W, Li H, Wang W. Li Y, et al. Among authors: he x. Anal Bioanal Chem. 2022 Jan;414(1):75-83. doi: 10.1007/s00216-021-03695-9. Epub 2021 Oct 25. Anal Bioanal Chem. 2022. PMID: 34693470 Review.

6

Research Progress of Conjugated Nanomedicine for Cancer Treatment.

Zhao B, Chen S, Hong Y, Jia L, Zhou Y, He X, Wang Y, Tian Z, Yang Z, Gao D. Zhao B, et al. Among authors: he x. Pharmaceutics. 2022 Jul 21;14(7):1522. doi: 10.3390/pharmaceutics14071522. Pharmaceutics. 2022. PMID: 35890416 Free PMC article. Review.

7

Iron metabolism, ferroptosis, and lncRNA in cancer: knowns and unknowns.

Qu L, He X, Tang Q, Fan X, Liu J, Lin A. Qu L, et al. Among authors: he x. J Zhejiang Univ Sci B. 2022 Oct 15;23(10):844-862. doi: 10.1631/jzus.B2200194. J Zhejiang Univ Sci B. 2022. PMID: 36226538 Free PMC article. Review.

8

Intelligent Nanomedicine Approaches Using Medical Gas-Mediated Multi-Therapeutic Modalities Against Cancer.

Ren X, Wang Y, Jia L, Guo X, He X, Zhao Z, Gao D, Yang Z. Ren X, et al. Among authors: he x. J Biomed Nanotechnol. 2022 Jan 1;18(1):24-49. doi: 10.1166/jbn.2022.3224. J Biomed Nanotechnol. 2022. PMID: 35180898 Review.

9

Biological stimuli-responsive cyclodextrin-based host-guest nanosystems for cancer therapy.

Dan Z, Cao H, He X, Zeng L, Zou L, Shen Q, Zhang Z. Dan Z, et al. Among authors: he x. Int J Pharm. 2015 Apr 10;483(1-2):63-8. doi: 10.1016/j.ijpharm.2015.01.035. Epub 2015 Jan 29. Int J Pharm. 2015. PMID: 25639701 Review.

10

Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics.

Zou L, Wang H, He B, Zeng L, Tan T, Cao H, He X, Zhang Z, Guo S, Li Y. Zou L, et al. Among authors: he x. Theranostics. 2016 Mar 21;6(6):762-72. doi: 10.7150/thno.14988. eCollection 2016. Theranostics. 2016. PMID: 27162548 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results